Clinical trial
Zestra in Women With Mixed Sexual Dysfunction
NCT00118495 · QualiLife Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00118495 |
|---|---|
| Title | Zestra in Women With Mixed Sexual Dysfunction |
| Official title | A Randomized, Placebo-Controlled, Double-Blind, Parallel Design Trial of the Efficacy and Safety of Zestra(TM) in Women With Mixed Desire/Interest/Arousal/Orgasm Disorders |
| Lead sponsor | QualiLife Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Sexual Dysfunction, Psychological |
| Intervention type | Drug |
| Interventions | Non-prescription Zestra(TM): patented formulation |
| Enrollment | 200 |
| Start date | Mar 1, 2006 |
| Completion | Mar 1, 2007 |
| First posted | Jul 11, 2005 |
| Last update posted | Jul 6, 2007 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: